Navigation Links
Rewriting a receptor's role
Date:2/19/2013

In a pair of new papers, researchers at the University of California, San Diego School of Medicine and the Royal Netherlands Academy of Arts and Sciences upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons, and describe how a compound linked to Alzheimer's disease impacts that receptor and weakens synaptic connections between brain cells.

The findings are published in the Feb. 18 early edition of the Proceedings of the National Academy of Sciences.

Long the object of study, the NMDA receptor is located at neuronal synapses the multitudinous junctions where brain cells trade electrical and chemical messages. In particular, NMDA receptors are ion channels activated by glutamate, a major "excitatory" neurotransmitter associated with cognition, learning and memory.

"NMDA receptors are well known to allow the passage of calcium ions into cells and thereby trigger biochemical signaling," said principal investigator Roberto Malinow, MD, PhD professor of neurosciences at UC San Diego School of Medicine.

The new research, however, indicates that NMDA receptors can also operate independent of calcium ions. "It turns upside down a view held for decades regarding how NMDA receptors function," said Malinow, who holds the Shiley-Marcos Endowed Chair in Alzheimer's Disease Research in Honor of Dr. Leon Thal (a renowned UC San Diego Alzheimer's disease researcher who died in a single-engine airplane crash in 2007).

Specifically, Malinow and colleagues found that glutamate binding to the NMDA receptor caused conformational changes in the receptor that ultimately resulted in a weakened synapse and impaired brain function.

They also found that beta amyloid a peptide that comprises the neuron-killing plaques associated with Alzheimer's disease causes the NMDA receptor to undergo conformational changes that also lead to the weakening of synapses.

"These new findings overturn commonly held views regarding synapses and potentially identify new targets in the treatment of Alzheimer's disease," said Malinow.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Group Therapy: New approach to psychosis treatment could target multiple nervous system receptors
2. Caffeines effect on the brains adenosine receptors visualized for the first time
3. Opioid receptors as a drug target for stopping obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Viewers who ... variety of critical historical facts, cultural practices, goods, services, and societal issues tend to ... will look into the popular practice of utilizing running events for causes around the ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in ... and leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance ... is designed to teach how to maximize their sales efforts, as well as ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion ... to Walk with God #TruthwithGrace” is the creation of published author Lea Michelle ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The ... silly dog who lives his life to the fullest, as God intended. “The Adventures ... Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, a ... medical technology for non-invasive surgery, announced today CE ... for treatment of uterine fibroids throughout the European ... received approval from the US Food and Drug ... Mirabilis System in the United States.  The Mirabilis ...
(Date:3/24/2017)... GENEVA , March 24, 2017 ... efforts to develop sutezolid as effective response to infectious ... TB Alliance and the Medicines Patent Pool (MPP) announced ... an antibiotic drug candidate which demonstrated encouraging results in ... sutezolid in combination with other TB drugs and follows ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Cryostat Market ... the next decade to reach approximately $3.5 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology: